Cargando…
Collaborative studies on the development of national reference standards for potency determination of H7N9 influenza vaccine
The outbreak of human infections of a novel avian influenza virus A (H7N9) prompted the development of the vaccines against this virus. Like all types of influenza vaccines, H7N9 vaccine must be tested for its potency prior to being used in humans. However, the unavailability of international refere...
Autores principales: | Li, Changgui, Xu, Kangwei, Hashem, Anwar, Shao, Ming, Liu, Shuzhen, Zou, Yong, Gao, Qiang, Zhang, Yongchao, Yuan, Liyong, Xu, Miao, Li, Xuguang, Wang, Junzhi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4514420/ https://www.ncbi.nlm.nih.gov/pubmed/25970793 http://dx.doi.org/10.1080/21645515.2015.1032490 |
Ejemplares similares
-
A neuraminidase activity-based microneutralization assay for evaluating antibody responses to influenza H5 and H7 vaccines
por: Zhao, Hui, et al.
Publicado: (2018) -
A Novel Synthetic Receptor-Based Immunoassay for Influenza Vaccine Quantification
por: Hashem, Anwar M., et al.
Publicado: (2013) -
Universal type/subtype-specific antibodies for quantitative analyses of neuraminidase in trivalent influenza vaccines
por: Xu, Kangwei, et al.
Publicado: (2018) -
A universal monoclonal antibody protects against all influenza A and B viruses by targeting a highly conserved epitope in the viral neuraminidase
por: Doyle, Tracey M, et al.
Publicado: (2014) -
A simple and safe antibody neutralization assay based on polio pseudoviruses
por: Jiang, Zheng, et al.
Publicado: (2018)